RA0303

antibody from Oursmab

Targeting: ICOS AILIM, CD278

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0303

Provider

Oursmab

Product name

Vopratelimab (Biosimilar Reference Antibody) (ICOS)

Antibody type

Monoclonal

Description

Vopratelimab (JTX-4014) is an investigational humanized monoclonal antibody that targets and acts as an agonist of the Inducible T-cell Co-stimulator (ICOS). It is being developed for cancer immunotherapy, aiming to enhance anti-tumor T-cell responses by selectively activating and expanding tumor-reactive T cells that express ICOS.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Vopratelimab (Biosimilar Reference Antibody) (ICOS)-RA0303-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Vopratelimab biosimilar in a linear range of 3.91-500 ng/mL.